# Rockwell Medical (RMTI) — Earnings

RMTI · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rmti/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.34 |
| EPS estimate | −$0.24 |
| EPS surprise | −44.68% |
| Revenue surprise | −0.22% |
| Revenue | $17.8M |
| Revenue estimate | $17.8M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1041024/000162828026056461/rmti-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/241de46c-92e0-3a39-93a7-967e06e72711.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 13, 2026 | −$0.24 | −$0.34 | -44.68% | $17.8M | $17.8M |
| Q1 2026 | May 7, 2026 | −$0.25 | −$4.00 | -1500.00% | $18.0M | $17.3M |
| Q4 2025 | Mar 26, 2026 | $0.20 | −$1.00 | -600.00% | $18.6M | $18.3M |
| Q3 2025 | Nov 12, 2025 | −$0.45 | −$0.50 | -11.11% | $16.2M | $15.9M |
| Q2 2025 | Aug 14, 2025 | −$0.50 | −$0.50 | 0.00% | $16.3M | $16.1M |
| Q1 2025 | May 12, 2025 | −$0.50 | −$0.40 | 20.00% | $17.5M | $18.9M |
| Q4 2024 | Mar 20, 2025 | $0.03 | −$0.20 | -700.60% | $23.5M | $24.7M |
| Q3 2024 | Nov 12, 2024 | $0.10 | $0.50 | 400.00% | $26.5M | $28.3M |
| Q2 2024 | Aug 8, 2024 | −$0.35 | $0.10 | 128.57% | $22.9M | $25.8M |
| Q1 2024 | May 14, 2024 | −$0.40 | −$0.60 | -50.00% | $21.7M | $22.7M |
| Q4 2023 | Mar 21, 2024 | −$0.70 | −$0.50 | 28.57% | $22.6M | $22.1M |
| Q3 2023 | Nov 14, 2023 | −$1.05 | −$0.70 | 33.33% | $22.8M | $23.8M |
| Q2 2023 | Aug 14, 2023 | −$1.20 | −$1.80 | -50.00% | $18.1M | $18.1M |
| Q1 2023 | May 15, 2023 | −$1.65 | −$1.00 | 39.39% | $19.1M | $19.7M |
| Q4 2022 | Mar 30, 2023 | −$3.90 | −$2.00 | 48.72% | $16.3M | $19.3M |
| Q3 2022 | Nov 14, 2022 | −$4.85 | −$4.00 | 17.53% | $19.4M | $18.7M |
| Q2 2022 | Aug 15, 2022 | −$8.10 | −$5.60 | 30.86% | $16.8M | $18.7M |
| Q1 2022 | May 16, 2022 | −$9.90 | −$8.40 | 15.15% | $18.8M | $16.1M |
| Q4 2021 | Apr 8, 2022 | −$9.90 | −$11.00 | -11.11% | $17.7M | $15.3M |
| Q3 2021 | Nov 15, 2021 | −$8.25 | −$8.80 | -6.67% | $18.2M | $16.0M |

## Frequently Asked Questions

### When did Rockwell Medical (RMTI) last report earnings?

Rockwell Medical last reported on Aug 13, 2026, covering fiscal Q2 2026.

### Did RMTI beat earnings estimates?

No. Rockwell Medical reported EPS of −$0.34 for Q2 2026 against a −$0.24 estimate — a 44.68% miss.

### How much revenue did RMTI report last quarter?

Rockwell Medical reported $17.8M in revenue for Q2 2026, against a consensus estimate of $17.8M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).